![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 4, 2414-2420, January 23, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





From the
Department of Biochemistry, University of Bristol, Bristol BS8 1TD, United Kingdom, the ¶Department of Biological Sciences, University of Essex, Colchester CO4 3SQ, United Kingdom, the ||Department of Clinical Biochemistry, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, United Kingdom, the **Tokyo Blood Center, Japanese Red Cross, Tokyo 150-0012, Japan, and the 
Department of Physiology, Emory University School of Medicine, Atlanta, Georgia 30322
We have studied the properties of band 3 in different glycophorin A (GPA)-deficient red cells. These red cells lack either both GPA and glycophorin B (GPB) (MkMk cells) or GPA (En(a) cells) or contain a hybrid of GPA and GPB (MiV cells). Sulfate transport was reduced in all three red cell types to
60% of that in normal control red cells as a result of an increased apparent Km for sulfate. Transport of the monovalent anions iodide and chloride was also reduced. The reduced iodide transport resulted from a reduction in the Vmax for iodide transport. The anion transport site was investigated by measuring iodide fluorescence quenching of eosin-5-maleimide (EMA)-labeled band 3. The GPA-deficient cells had a normal Kd for iodide binding, in agreement with the unchanged Km found in transport studies. However, the apparent diffusion quenching constant (Kq) was increased, and the fluorescence polarization of band 3-bound EMA decreased in the variant cells, suggesting increased flexibility of the protein in the region of the EMA-binding site. This increased flexibility is probably associated with the decrease in Vmax observed for iodide transport. Our results suggest that band 3 in the red cell can take up two different structures: one with high anion transport activity when GPA is present and one with lower anion transport activity when GPA is absent.
Received for publication, September 4, 2003 , and in revised form, November 3, 2003.
* This work was supported in part by grants from the Wellcome Trust (to M. J. A. T. and R. J. C.) and by National Institutes of Health Grant HL-66173 (to R. B. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Bristol Institute of Transfusion Sciences, Southmead Rd., Bristol BS10 5NB, UK. Tel.: 44-117-991-2126; Fax: 44-117-959-1660; E-mail: lesley.bruce{at}nbs.nhs.uk.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Takazaki, Y. Abe, D. Kang, C. Li, X. Jin, T. Ueda, and N. Hamasaki The functional role of arginine 901 at the C-terminus of the human anion transporter band 3 protein. J. Biochem., May 1, 2006; 139(5): 903 - 912. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |